Quang X. Pham
CEO and Chairman at Cadrenal Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cadrenal Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cadrenal Therapeutics Inc. September 24, 202698.6%
-
Cadrenal Therapeutics Inc. October 20, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −7,400 | $3.03 | $22,422 |
| Jun 26, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −9,029 | $3.05 | $27,538 |
| Jun 25, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,127 | $3.00 | $6,381 |
| Jun 23, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,277 | $3.20 | $7,286 |
| Jun 22, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −9,167 | $3.55 | $32,543 |
| Jun 17, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −513 | $3.16 | $1,621 |
| Jun 16, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,613 | $3.18 | $11,489 |
| Jun 15, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,666 | $3.58 | $13,124 |
| Jun 12, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −12,996 | $3.94 | $51,204 |
| Jun 11, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −1,462 | $4.12 | $6,023 |
| Jun 10, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,500 | $4.21 | $14,735 |
| Jun 9, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −12,992 | $4.06 | $52,748 |
| Jun 8, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −5,893 | $4.38 | $25,811 |
| Jun 5, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,064 | $4.42 | $9,123 |
| Jun 4, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,898 | $4.41 | $17,190 |
Questions about Quang X. Pham
What boards is Quang X. Pham on?
Quang X. Pham sits on the board of Cadrenal Therapeutics Inc.
What company is Quang X. Pham the CEO of?
Quang X. Pham has been CEO and Chairman of Cadrenal Therapeutics Inc. since January 2023.
How long has Quang X. Pham served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.